Ayala Pharmaceuticals, Inc. (ADXS)
OTCMKTS · Delayed Price · Currency is USD
0.0347
0.00 (0.00%)
Aug 1, 2025, 9:46 AM EDT
Verve Therapeutics Market Cap
Ayala Pharmaceuticals has a market cap or net worth of $1.98 million as of August 1, 2025. Its market cap has decreased by -70.85% in one year.
Market Cap
1.98M
Enterprise Value
5.41M
Revenue
13.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since October 19, 2023, Ayala Pharmaceuticals's market cap has decreased from 9.68M to 1.98M, a decrease of -79.57%. That is a compound annual growth rate of -59.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 1.98M | 48.52% |
| Dec 31, 2024 | 1.33M | -83.23% |
| Dec 29, 2023 | 7.94M | -18.00% |
| Oct 19, 2023 | 9.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |